Third Rock Ventures III L.P. 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Unchanged | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures III L.P. | 2,343,154 3.800% | 0 (Unchanged) | Filing |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures III L.P. | 2,343,154 4.500% | -1,703,271 (-42.09%) | Filing |
| 2022-02-14 5:06 pm Sale | 2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures III L.P. | 4,046,425 10.000% | -1,915,777 (-32.13%) | Filing |